Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
3-5 November 2026
RAIAmsterdam, Netherlands

Louis Diorazio, PhD
Senior Principal Scientist, New Modalities at AstraZeneca
Speaker

Profile

Louis Diorazio is Senior Principal Scientist for New Modalities in AstraZeneca’s Chemical Development group based in Macclesfield UK. He obtained a BSc and PhD from Imperial College, London on aromatic fluorination followed by postdoctoral studies with Prof. Phil Magnus in the field of natural product synthesis. He has 32 years industry experience across small molecules and new modalities from discovery activities through to commercialisation. A long term feature of his activities has been driving a development culture focused on sustainable processing through training and collaboration.

Agenda Sessions

  • Rethinking Green Credentials for Oligo Manufacturing

    09:05